Molecular Oncology

Article	Citations
Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy	195
From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021‐lessons learned and implications	95
	85
Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients	82
An arms‐race against resistance: leukemic stem cells and lineage plasticity	79
The synthetic oleanane triterpenoid CDDO‐2P‐Im binds GRP78/BiP to induce unfolded protein response‐mediated apoptosis in myeloma	74
Issue Information	65
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas	62
Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance	61
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study	58
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma	57
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”	50
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”	49
The polyamine transporter ATP13A3 mediates difluoromethylornithine‐induced polyamine uptake in neuroblastoma	49
Cytokine‐centered strategies to boost cancer immunotherapy	48
Copy number variations contribute to malignant tumor development in children with serious birth defects	48
Tonabersat enhances temozolomide‐mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition	47
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival	43
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer	40
Pogo transposons provide tools to restrict cancer growth	40
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and pred	37
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling	35
Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread	34
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO	34
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma	33

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer	33
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer	32
A new function for the serine protease HtrA2 in controlling radiation‐induced senescence in cancer cells	32
Issue Information	30
Navigating the current landscape of scientific publishing – the Molecular Oncology perspective	30
Postbiotics of Lacticaseibacillus paracaseiCECT 9610 and Lactiplantibacillus plantarumCECT 9608 attenuates store‐operated calcium entry and FAK phosphory	30
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients	29
Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing	29
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection	29
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth	29
A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer	29
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4	29
Issue Information	28
	28
Issue Information	28
mitoSomatic: a tool for accurate identification of mitochondrial DNA somatic mutations without paired controls	28
Issue Information	27
Issue Information	27
DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis	26
	26
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network	26
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL	26
	25
Issue Information	25
‘Strategic’ development of precision cancer medicine in the United States	25
Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma	25
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities	24
Overexpression of synaptic vesicle protein Rab GTPase 3C promotes vesicular exocytosis and drug resistance in colorectal cancer cells	24
Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells	24
A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity	24
Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly	24
Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2+ mononuclear phagocyte differentiation in liver cancer	24
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome	24
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population	24
Exploiting signaling rewiring in cancer cells with co‐existing oncogenic drivers	23
	23
From bedside to portable and wearable: development of a conformable ultrasound patch for deep breast tissue imaging	23
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity	23
	23
Sphingosine‐1‐phosphate‐lyase deficiency affects glucose metabolism in a way that abets oncogenesis	23
	22
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer	22
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo	22
Links between melanoma germline risk loci, driver genes and comorbidities: insight from a tissue‐specific multi‐omic analysis	22
Immune escape of colorectal tumours via local LRH‐1/Cyp11b1‐mediated synthesis of immunosuppressive glucocorticoids	22
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer	21
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma	21
Mesenchymal tumor cells drive adaptive resistance of Trp53−/− breast tumor cells to inactivated mutant Kras	21
Precision Cancer Medicine 2.0—Oncology in the postgenomic era	21
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy	20

Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level	20
Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis	20
Slow‐replicating leukemia cells represent a leukemia stem cell population with high cell‐surface CD74 expression	20
Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice	20
Osteoblast‐derived extracellular vesicles exert osteoblastic and tumor‐suppressive functions via SERPINA3 and LCN2 in prostate cancer	19
The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells	19
Enhanced reversal of ABCG2‐mediated drug resistance by replacing a phenyl ring in baicalein with a meta‐carborane	19
Hot on RAD51C: structure and functions of RAD51C‐XRCC3	19
Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural‐like dedifferentiation	19
	19
SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A–c‐Myc axis	19
Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis	19
Pellino 3 promotes the colitis‐associated colorectal cancer through suppression of IRF4‐mediated negative regulation of TLR4 signalling	18
KSR induces RAS‐independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors	18
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer	18
Vitamin‐C‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest	18
NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC: translational research of phase III IMP	18
Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma	17
Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells	17
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study	17
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR‐15b‐5p and miR‐7‐1‐3p processing in nasopharyngeal carcinoma	17
Metabolism in the tumor cell and beyond	17
Revisiting CDKN2A dysregulation in Ewing sarcoma	17
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma	17
	17
The CK1ε/SIAH1 axis regulates AXIN1 stability in colorectal cancer cells	17
Immune evasion: An imperative and consequence of MYC deregulation	17
Upregulated functional gene expression programmes in tumour pericytes mark progression in patients with low‐grade glioma	17
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM	17
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1	17
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing	17
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients	17
Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis	17
Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures	16
E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models	16
Alone you go faster, together you go farther	16
Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia‐inducible factor‐1α in colorectal cancer	16
Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers	16
Small nucleolar RNA SNORA71A promotes epithelial‐mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer	16
L1CAM promotes vasculogenic mimicry formation by miR‐143‐3p‐induced expression of hexokinase 2 in glioma	16
Issue Information	16
SMG1, a nonsense‐mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma	16
Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation	16
Tumour‐derived substrate‐adherent cells promote neuroblastoma survival through secreted trophic factors	16
	16
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin	16
Sweet dreams could be made of this: carbohydrate‐responsive element‐binding protein (ChREBP) as a target for hepatocellular carcinoma therapy	16
Dual role of GRHL3 in bladder carcinogenesis depending on histological subtypes	16
Issue Information	16
The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis	16
	16
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy	16
Single‐cell protein profiling defines cell populations associated with triple‐negative breast cancer aggressiveness	16
Platelet‐activating factor: a potential therapeutic target to improve cancer immunotherapy	15
High prevalence of unusualKRAS,NRAS, andBRAFmutations inPOLE‐hypermutated colorectal cancers	15
Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3	15
NICD3 regulates the expression of MUC5AC and MUC2 by recruiting SMARCA4 and is involved in the differentiation of mucinous colorectal adenocarcinoma	15
Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab	15
An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer	15
Targeting ferroptosis for improved radiotherapy outcomes in HPV‐negative head and neck squamous cell carcinoma	15
The MYC–NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells	15
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1	15
Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook	14
Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes	14
ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1	14
Corrigendum to: Small proline‐rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage‐induced apoptosis	14
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system	14
Bispecific antibodies come to the aid of cancer immunotherapy	14
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets	14
Novel CTRP8‐RXFP1‐JAK3‐STAT3 axis promotes Cdc42‐dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells	14
Corrigendum to: Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA	14
Fractionated irradiation of MCF7 breast cancer cells rewires a gene regulatory circuit towards a treatment‐resistant stemness phenotype	14
Effect of p53 and its N‐terminally truncated isoform, Δ40p53, on breast cancer migration and invasion	14
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer	14
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer	14
MND1 enables homologous recombination in somatic cells primarily outside the context of replication	14
ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells	13
Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma	13
Current status of precision oncology in adult glioblastoma	13
Retraction: p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance	13

The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours	13
Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors	13
SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapy	13
Single‐cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancer	12
HOX gene regulation in glioma stem cells, mediators of resistance in breast cancer, and paradoxical therapeutic interventions	12
ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma	12
Characterization of fragment sizes, copy number aberrations and 4‐mer end motifs in cell‐free DNA of hepatocellular carcinoma for enhanced liquid biopsy‐based cancer detection	12
Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression	12
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1–NDRG1 deregulation	12
Ageing and cancer: a research gap to fill	12
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling	12
Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer	12
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy	12
Strategies to decrease inequalities in cancer therapeutics, care and prevention	12
A standalone approach to utilize telomere length measurement as a surveillance tool in oral leukoplakia	12
TGFβ selects for pro‐stemness over pro‐invasive phenotypes during cancer cell epithelial–mesenchymal transition	12
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A	11
Calsequestrin 2 overexpression in breast cancer increases tumorigenesis and metastasis by modulating the tumor microenvironment	11
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations	11
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway	11
Thioredoxin‐interacting protein (TXNIP) is a substrate of the NEDD4‐like E3 ubiquitin‐protein ligase WWP1 in cellular redox state regulation of acute myeloi	11
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K	11
Single extracellular vesicle surface protein‐based blood assay identifies potential biomarkers for detection and screening of five cancers	11
Circular RNA circ‐TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR‐452‐5p/DAG1 axis	11
Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy	11
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer	11
ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling	11
Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer	11
Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis	11
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma	11
Exosomes secreted by ST3GAL5high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment	11
Fragment‐based drug discovery—the importance of high‐quality molecule libraries	11
Unveiling mutational dynamics in non‐small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA	11
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues	10
	10
	10
Cancer cachexia: biomarkers and the influence of age	10
Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma	10
ANGPTL2‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion	10
miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer	10
Epigenetic therapies for neuroblastoma: immunogenicity awakens	10
Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework	10
Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy	10
Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia	10
Issue Information	10
Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTOR	10
Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole‐exome sequencing	10
Patient‐derived preclinical models to develop immunotherapies	10
Data sharing and management in 21st century cancer research	10
Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model	10
Integrated analysis of racial disparities in genomic architecture identifies a trans‐ancestry prognostic subtype in bladder cancer	10
KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study	10
Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration	10
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts	10
Issue Information	9
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions	9
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage	9
Issue Information	9
The roles and applications of extracellular vesicles in cancer	9
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic–mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer	9
	9
	9
Focus on blood cancers and liquid biopsy research	9
The atypical KRASQ22K mutation directs TGF‐β response towards partial epithelial‐to‐mesenchymal transition in patient‐derived colorectal cancer tumoroids	9
Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity	9
Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location	9
RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells	9
Issue Information	9
	9
Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth	9
	9
Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC	9
Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC	9
Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study	9
Germline variants in CDKN2A wild‐type melanoma prone families	9
Decoding HPV: disease stage and treatment insights	9
The interplay between eosinophils and T cells in breast cancer immunotherapy	8
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma	8
UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation	8
	8
Target Finder of Transcription Factor (TFoTF): a novel tool to predict transcription factor‐targeted genes in cancer	8
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT rand	8
Targeting rapid TKI‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia	8
Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?	8
Shifting the paradigm in personalized cancer care through next‐generation therapeutics and computational pathology	8
Interferon regulatory factor 4 modulates epigenetic silencing and cancer‐critical pathways in melanoma cells	8
Issue Information	8
Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non‐exonic single‐nucleotide polymorphism‐based next‐generation sequencing panel	8
Issue Information	8
Lasting response by vertical inhibition with cetuximab and trametinib inKRAS‐mutated colorectal cancer patient‐derived xenografts	8
ALKing the flames of lung cancer immunosensitivity	8
Identifying the personalized driver gene sets maximally contributing to abnormality of transcriptome phenotype in glioblastoma multiforme individuals	8
Systematic analysis of migration factors by MigExpress identifies essential cell migration control genes in non‐small cell lung cancer	8
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms	8
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment	8